Ginkgo Bioworks Holdings (DNA) Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Current Assets for 7 consecutive years, with $332.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 36.42% year-over-year to $332.5 million; the trailing twelve-month figure through Jun 2026 stood at $332.5 million (down 36.42% YoY), and the FY2025 full-year result was $471.8 million, down 21.72% from the prior year.
• Current Assets eased to $332.5 million in Q2 2026 per DNA's latest filing, from $410.0 million in the prior quarter.
• Across five years, Current Assets topped out at $1.7 billion in Q1 2022 and bottomed at $332.5 million in Q2 2026.
• Historically, Current Assets has averaged $926.1 million across 5 years, with a median of $843.2 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Current Assets soared 165261.75% in 2022, then sank 41.98% in 2024.
• Over 5 years, Current Assets stood at $1.5 billion in 2022, then sank by 30.92% to $1.0 billion in 2023, then tumbled by 39.83% to $602.7 million in 2024, then decreased by 21.72% to $471.8 million in 2025, then fell by 29.52% to $332.5 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $332.5 million, $410.0 million, and $471.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.